Samsung Biologics Co.,Ltd. (207940.KS)
KRW 959000.0
(-2.14%)
KRW 959000.0
(-2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1666.22 Billion | 953.04 Billion | 454.59 Billion | 202.09 Billion | 10.15 Billion | -32.41 Billion |
| Net Income | 857.69 Billion | 798.05 Billion | 393.58 Billion | 240.97 Billion | 202.9 Billion | 224.1 Billion |
| Depreciation & Amortization | 489.78 Billion | 308.26 Billion | 161.78 Billion | 143.68 Billion | 132.88 Billion | 91.45 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 298.74 Billion | -263.48 Billion | -234.84 Billion | -203.53 Billion | -187.88 Billion | -188.97 Billion |
| Other non-cash items | 20.01 Billion | 110.21 Billion | 134.05 Billion | 20.96 Billion | -137.74 Billion | -158.99 Billion |
| Investing Cash Flow | -1566.3 Billion | -3106.47 Billion | -933.48 Billion | -418.68 Billion | 339.64 Billion | -631.98 Billion |
| Investments in PPE | -1105.32 Billion | -1009.22 Billion | -421.15 Billion | -148.56 Billion | -181.19 Billion | -284.45 Billion |
| Acquisitions | -1079.93 Billion | -1097.33 Billion | -12.37 Billion | 8.9 Billion | -18.1 Billion | 743.05 Billion |
| Investment purchases | -7849.56 Billion | -12428.05 Billion | -5840 Billion | -4380.16 Billion | -4320 Billion | -4570.6 Billion |
| Sales/Maturities of investments | 8465.72 Billion | 11427.88 Billion | 5340 Billion | 4110 Billion | 4880 Billion | 3480 Billion |
| Other Investing Activities | 2.78 Billion | 242.52 Million | 37.63 Million | -8.85 Billion | -21.06 Billion | 13.2 Million |
| Financing Cash Flow | -635.04 Billion | 3000.08 Billion | 496.62 Billion | 122.56 Billion | -239.8 Billion | 323.94 Billion |
| Debt repayment | -1280.84 Billion | -937.34 Billion | -190.98 Billion | -401.65 Billion | -386.58 Billion | -68.75 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3200.75 Billion | - | - | - | - |
| Other Financing Activities | 645.79 Billion | 736.67 Billion | 687.6 Billion | 524.21 Billion | 146.77 Billion | 392.69 Billion |
| Accounts receivables | -15.57 Billion | -356.57 Billion | -176.65 Billion | -107.52 Billion | -121.65 Billion | -95.79 Billion |
| Accounts payables | 267.03 Billion | 134.59 Billion | 21.05 Billion | 58.25 Billion | -150.25 Million | -13.31 Billion |
| Inventory | -273.89 Billion | -179.91 Billion | -370.57 Billion | -184.88 Billion | -156.32 Billion | -90.44 Billion |
| Other working capital | 321.17 Billion | 138.4 Billion | 291.32 Billion | 30.62 Billion | 90.24 Billion | -98.53 Billion |
| Cash at beginning of period | 890.81 Billion | 47.41 Billion | 28.85 Billion | 125.1 Billion | 17.62 Billion | 358.08 Billion |
| Cash at end of period | 367.93 Billion | 890.81 Billion | 47.41 Billion | 28.85 Billion | 125.1 Billion | 17.62 Billion |
| Capital Expenditure | -1105.32 Billion | -1009.22 Billion | -421.15 Billion | -148.56 Billion | -181.19 Billion | -284.45 Billion |
| Effect of forex changes on cash | 12.24 Billion | -3.24 Billion | 831.1 Million | -2.21 Billion | -2.51 Billion | 10.00 |
| Net cash flow / Change in cash | -522.88 Billion | 843.4 Billion | 18.56 Billion | -96.25 Billion | 107.47 Billion | -340.46 Billion |
| Free Cash Flow | 560.9 Billion | -56.17 Billion | 33.44 Billion | 53.52 Billion | -171.04 Billion | -316.87 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 317.99 Billion | 179.36 Billion | 290.68 Billion | 857.69 Billion | 240.36 Billion | 184.88 Billion |
| Depreciation & Amortization | 148.04 Billion | 143.41 Billion | 141.94 Billion | 489.78 Billion | 138.52 Billion | 108.63 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -349.91 Billion | -124.4 Billion | 361.91 Billion | 298.74 Billion | -136.5 Billion | -25.44 Billion |
| Other non-cash items | 123.33 Billion | 467.82 Billion | 38.31 Billion | 20.01 Billion | 49.02 Billion | -42.84 Billion |
| Investing Cash Flow | -317 Billion | 584.91 Billion | -449.75 Billion | -1566.3 Billion | -372.31 Billion | -1134.69 Billion |
| Investments in PPE | -104.09 Billion | -112.81 Billion | -299.01 Billion | -1105.32 Billion | -159.38 Billion | -169.29 Billion |
| Acquisitions | -601.95 Billion | -1.86 Billion | -213.84 Million | -1079.93 Billion | -12.37 Billion | 10.22 Billion |
| Investment purchases | -1052.27 Billion | -1050.4 Billion | -1650.65 Billion | -7849.56 Billion | -1500.55 Billion | -1414.52 Billion |
| Sales/Maturities of investments | 1457 Billion | 1750 Billion | 1500 Billion | 8465.72 Billion | 1300 Billion | 1513.83 Billion |
| Other Investing Activities | 389.04 Billion | 10.00 | 131.49 Million | 2.78 Billion | 4 Million | -1074.92 Billion |
| Financing Cash Flow | -32.47 Billion | -202.28 Billion | -285.51 Billion | -635.04 Billion | -179.36 Billion | -84.36 Billion |
| Debt repayment | -52.47 Billion | -132.5 Billion | -659.51 Billion | -1280.84 Billion | -364 Billion | -140.97 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -200 Million | - | 80 Million | 120 Million |
| Other Financing Activities | 20 Billion | - | 374.2 Billion | 645.79 Billion | 184.55 Billion | 56.48 Billion |
| Accounts receivables | -211.3 Billion | -9.23 Billion | 108.76 Billion | -15.57 Billion | -280.37 Billion | -39.76 Billion |
| Accounts payables | 102.94 Billion | -37.63 Billion | 141.24 Billion | 267.03 Billion | 20.59 Billion | 68.69 Billion |
| Inventory | -109.01 Billion | -42.65 Billion | -107.49 Billion | -273.89 Billion | -19.12 Billion | -83.48 Billion |
| Other working capital | -29.59 Billion | -34.87 Billion | 219.4 Billion | 321.17 Billion | 142.4 Billion | 29.11 Billion |
| Cash at beginning of period | 1060.08 Billion | 367.93 Billion | 279.18 Billion | 890.81 Billion | 534.81 Billion | 1522.19 Billion |
| Cash at end of period | 973.5 Billion | 1060.08 Billion | 367.93 Billion | 367.93 Billion | 279.18 Billion | 534.81 Billion |
| Capital Expenditure | -104.09 Billion | -112.81 Billion | -299.01 Billion | -1105.32 Billion | -159.38 Billion | -169.29 Billion |
| Effect of forex changes on cash | 23.45 Billion | 19.67 Billion | -8.83 Billion | 12.24 Billion | 4.64 Billion | 6.45 Billion |
| Net cash flow / Change in cash | -86.57 Billion | 692.14 Billion | 88.75 Billion | -522.88 Billion | -255.63 Billion | -987.37 Billion |
| Free Cash Flow | 135.37 Billion | 177.03 Billion | 533.84 Billion | 560.9 Billion | 132.01 Billion | 55.93 Billion |
5542
M2R
9526
BCHN
7883
1108